Related references
Note: Only part of the references are listed.Toxin A-Predominant Pathogenic Clostridioides difficile: A Novel Clinical Phenotype
Qianyun Lin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain
T. J. Carlson et al.
ANAEROBE (2020)
PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255
Anne J. Gonzales-Luna et al.
EMERGING MICROBES & INFECTIONS (2020)
Trends in US Burden of Clostridioides difficile Infection and Outcomes
Alice Y. Guh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clostridioides (Formerly Clostridium) difficile Infection During Hospitalization Increases the Likelihood of Nonhome Patient Discharge
Kelly R. Reveles et al.
CLINICAL INFECTIOUS DISEASES (2019)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Changes in Prevalence of Health Care-Associated Infections in US Hospitals
S. S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study
D. N. Shah et al.
JOURNAL OF HOSPITAL INFECTION (2016)
In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent
Samuel L. Aitken et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2015)
Evaluation of Portability and Cost of a Fluorescent PCR Ribotyping Protocol for Clostridium difficile Epidemiology
Jonathan N. V. Martinson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection
Isaac See et al.
CLINICAL INFECTIOUS DISEASES (2014)
Real-Time Polymerase Chain Reaction Detection of Asymptomatic Clostridium difficile Colonization and Rising C. difficile-Associated Disease Rates
Hoonmo L. Koo et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2014)
Clostridium difficile infection Toxins and non-toxin virulence factors, and their contributions to disease establishment and host response
Gayatri Vedantam et al.
GUT MICROBES (2012)
Clostridium difficile infection: Historic review
John G. Bartlett
ANAEROBE (2009)
Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors
F. Sundram et al.
JOURNAL OF HOSPITAL INFECTION (2009)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality
VG Loo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
An epidemic, toxin gene-variant strain of Clostridium difficile
LC McDonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
